Invesco Health Care Fund Class Y (GGHYX)
Fund Assets | 1.47B |
Expense Ratio | 0.81% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 1.84 |
Dividend Yield | 4.92% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Dec 16, 2024 |
Previous Close | 37.09 |
YTD Return | 0.51% |
1-Year Return | -3.91% |
5-Year Return | 22.83% |
52-Week Low | 35.38 |
52-Week High | 44.52 |
Beta (5Y) | n/a |
Holdings | 82 |
Inception Date | Oct 3, 2008 |
About GGHYX
The Fund's investment strategy focuses on GL Health/Biotech with 0.81% total expense ratio. The minimum amount to invest in AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class Y Shares is $1,000 on a standard taxable account. AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class Y Shares seeks long-term growth of capital. GGHYX invests, under normal circumstances, at least 80% of its net assets in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities.
Performance
GGHYX had a total return of -3.91% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.14%.
Top 10 Holdings
51.30% of assetsName | Symbol | Weight |
---|---|---|
Boston Scientific Corporation | BSX | 8.90% |
Eli Lilly and Company | LLY | 8.70% |
UnitedHealth Group Incorporated | UNH | 6.32% |
Stryker Corporation | SYK | 4.54% |
AbbVie Inc. | ABBV | 4.26% |
Vertex Pharmaceuticals Incorporated | VRTX | 4.15% |
Cencora, Inc. | COR | 4.11% |
Intuitive Surgical, Inc. | ISRG | 4.02% |
Short-Term Investment Trust - Invesco Treasury Portfolio | TRPXX | 3.50% |
Abbott Laboratories | ABT | 2.80% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
Dec 15, 2020 | $0.5793 | Dec 15, 2020 |
Dec 13, 2019 | $1.5683 | Dec 13, 2019 |
Dec 14, 2018 | $2.9024 | Dec 14, 2018 |
Dec 13, 2017 | $2.4481 | Dec 13, 2017 |